Adipokines are signaling proteins involved in metabolic, endocrinological, vascular and immunogenic processes. Associations of various adipokines with not only insulin resistance but also with increased insulin sensitivity, increased systolic blood pressure, and atherosclerosis highlight the significance of adipokines in several components of metabolic syndrome and metabolic diseases in general. As pregnancy presents a unique metabolic state, the role of adipokines in pregnancy, and even in various pregnancy complications, appears to be key to elucidating these metabolic processes. Many studies in recent years have attempted to clarify the role of adipokines in pregnancy and gestational pathologies. In this review, we aim to investigate the changes in maternal adipokine levels in physiological gestation, as well as the association of adipokines with pregnancy pathologies, such as gestational diabetes mellitus (GDM) and preeclampsia (PE). Furthermore, we will analyze the association of adipokines in both maternal serum and cord blood with parameters of intrauterine growth and various pregnancy outcomes.
Institut(e)Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
FörderungenEFSD Mentorship Programme - AstraZeneca Swedish Kidney Foundation (Njurfonden) Deutsche Diabetes Gesellschaft (DDG) Stiftelsen Stig och Gunborg Westman Karolinska Institutet Research Foundation Karolinska Institutet, Stockholm, Sweden Novo Nordisk postdoctoral fellowship medical faculty of the University of Leipzig German Diabetes Association (DDG) Deutsches Zentrum fur Diabetesforschung (DZD) Deutsche Forschungsgemeinschaft (DFG, German Research foundation)